The Compass Rose Health Plan is expanding access to preventive screenings through a new partnership with Molecular Testing Labs (MTL), helping eligible members complete certain recommended health screenings from the comfort of home.

Preventive screenings play an important role in detecting health conditions early, often before symptoms appear. Early detection can improve treatment options and health outcomes, making routine screening an important part of maintaining overall health.

Through this partnership, select eligible members may receive an at-home screening kit by mail based on their health needs and screening history. These kits are provided at no cost to eligible members and can be completed at home and returned using prepaid mailing materials. Samples are processed by a CLIA-licensed, CAP-accredited laboratory.

The Importance of Screening

Screening helps identify potential health concerns early, when treatment may be most effective.

Colorectal Cancer Screening

Colorectal cancer is the third most commonly diagnosed cancer in both men and women and the second leading cause of cancer-related death in the United States.1 According to the American Cancer Society's Colorectal Cancer Facts & Figures report, nearly 159,000 new cases of colorectal cancer are expected to be diagnosed in the United States in 2026. 

Regular screening can help detect colorectal cancer at earlier stages. A Fecal Immunochemical Test (FIT) is an effective screening option for detecting signs of colorectal cancer. The U.S. Preventive Services Task Force (USPSTF) recommends annual FIT colorectal cancer screening in average-risk adults aged 45 to 75.

Cervical Cancer Screening

Cervical cancer screening is also an important preventive service. Most cervical cancers are linked to human papillomavirus (HPV), and regular screening can help detect abnormal cell changes before they become cancerous. 

According to the American Cancer Society, many cases of cervical cancer can be prevented through screening and appropriate follow-up care.2 The USPSTF recommends routine cervical cancer screening for average-risk women and individuals with a cervix aged 21 to 65. Guidelines vary by age, utilizing either cervical cytology (Pap test) or high-risk human papillomavirus (hrHPV) testing. As part of this program, eligible members will receive an at-home HPV screening kit.

A1c Testing

An A1c test measures your average blood sugar levels over the past two to three months. It can help identify prediabetes or diabetes, often before symptoms develop. It is also an important tool for people with diabetes, helping monitor how well your blood sugar is being managed over time.

Routine blood tests are an important part of preventive care and diabetes management. According to the Centers for Disease Control and Prevention, more than 40 million Americans have diabetes.3 By identifying potential concerns early and monitoring ongoing health conditions, these screenings can help individuals take proactive steps to protect their long-term health.

What Members Should Expect

Not all members will receive a screening kit. Eligible members may be identified based on age, health history, screening status, or other clinical factors.

Members who receive a kit should review the instructions carefully and complete and return their sample as soon as possible. Results are confidential and should be shared with a primary care provider during routine care visits.

Eligible High Option members and covered spouses may be able to earn Wellness Rewards points for completing certain screenings or meeting health targets. Members must opt in to the Wellness Rewards Program each year before they can begin earning rewards.

By expanding access to convenient at-home screening options, Compass Rose Health Plan continues its commitment to helping members stay up to date on recommended preventive care and take proactive steps to support their long-term health.


1
https://www.cancer.org/cancer/types/colon-rectal-cancer/about/key-statistics.html
2 https://www.cancer.org/cancer/types/cervical-cancer/detection-diagnosis-staging/cervical-cancer-screening-guidelines.html
3 https://www.cdc.gov/diabetes/php/data-research/index.html